For a menopause-related search, choose a source category below. These categories also contain products for other uses; they are not a list of suitable treatments.
HORMONES AND SUBSTITUTES
Browse ingredients, then choose a strength and product. Ontario inventory only; not a treatment recommendation.
DAPAGLIFLOZIN: products 1 to 20 of 22.
Prices below are the ministry's recorded amounts per source unit, not pharmacy quotes or the patient's payment. Different strengths, forms and package units are not directly comparable. The cost plan asks for quantity and refill details.
| Product / strength / form | Ontario listing | Recorded ministry price | Next step |
|---|---|---|---|
| Accel-Dapagliflozin 10mg TabDIN 02543192 | General benefit | $0.5220per source unit | Requirements & sourcesBuild cost plan |
| Accel-Dapagliflozin 5mg TabDIN 02543184 | General benefit | $0.5220per source unit | Requirements & sourcesBuild cost plan |
| Apo-Dapagliflozin 10mg TabDIN 02527197 | General benefit | $0.5220per source unit | Requirements & sourcesBuild cost plan |
| Apo-Dapagliflozin 5mg TabDIN 02527189 | General benefit | $0.5220per source unit | Requirements & sourcesBuild cost plan |
| Auro-Dapagliflozin 10mg TabDIN 02531410 | General benefit | $0.5220per source unit | Requirements & sourcesBuild cost plan |
| Auro-Dapagliflozin 5mg TabDIN 02531402 | General benefit | $0.5220per source unit | Requirements & sourcesBuild cost plan |
| Dapagliflozin 10mg TabDIN 02561336 | General benefit | $0.5220per source unit | Requirements & sourcesBuild cost plan |
| Dapagliflozin 5mg TabDIN 02561328 | General benefit | $0.5220per source unit | Requirements & sourcesBuild cost plan |
| Forxiga 10mg TabDIN 02435470 | General benefit | $0.5220per source unit | Requirements & sourcesBuild cost plan |
| Forxiga 5mg TabDIN 02435462 | General benefit | $0.5220per source unit | Requirements & sourcesBuild cost plan |
| GLN-Dapagliflozin 10mg TabDIN 02519860 | General benefit | $0.5220per source unit | Requirements & sourcesBuild cost plan |
| GLN-Dapagliflozin 5mg TabDIN 02519852 | General benefit | $0.5220per source unit | Requirements & sourcesBuild cost plan |
| Jamp Dapagliflozin 10mg TabDIN 02531372 | General benefit | $0.5220per source unit | Requirements & sourcesBuild cost plan |
| Jamp Dapagliflozin 5mg TabDIN 02531364 | General benefit | $0.5220per source unit | Requirements & sourcesBuild cost plan |
| M-Dapagliflozin 10mg TabDIN 02535300 | General benefit | $0.5220per source unit | Requirements & sourcesBuild cost plan |
| M-Dapagliflozin 5mg TabDIN 02535297 | General benefit | $0.5220per source unit | Requirements & sourcesBuild cost plan |
| NRA-Dapagliflozin 10mg TabDIN 02538342 | General benefit | $0.5220per source unit | Requirements & sourcesBuild cost plan |
| NRA-Dapagliflozin 5mg TabDIN 02538334 | General benefit | $0.5220per source unit | Requirements & sourcesBuild cost plan |
| PMS-Dapagliflozin 10mg TabDIN 02531569 | General benefit | $0.5220per source unit | Requirements & sourcesBuild cost plan |
| PMS-Dapagliflozin 5mg TabDIN 02531550 | General benefit | $0.5220per source unit | Requirements & sourcesBuild cost plan |
Not seeing a product? Search Canadian records by medication name or DIN. Absence from this Ontario extract does not establish non-coverage. Open an exact product for its dated Health Canada status; a listing is not a stock check.
Class sources and program rules
Ontario Ministry of Health: odb-formulary-ed43-extract-2026-08-26.xml, extract 2026-08-26. Ontario class index: formulary-ed43-front-matter.txt, Part V.
68:00 HORMONES AND SUBSTITUTES.
68:04 Corticosteroids.
68:08 Androgens.
68:12 Contraceptives.
68:16 Estrogens.
68:20:02 Oral Anti-Diabetic Agents.
68:20:06 Incretin Mimetics.
68:20:10 Insulins (Rapid Acting).
68:20:12 Insulins (Intermediate Acting).
68:20:14 Insulins (Long Acting).
68:20:16 Insulins (Pre-Mixed).
68:24 Parathyroid Agents.
68:28 Pituitary Agents.
68:32 Progestogens and Oral Contraceptives.
68:36 Thyroids.
68:38 Anti-Thyroids.
National Defence, WDH Guide to Menopause, 2026-09-17
Hormone Therapy (HT) previously called Hormone Replacement Therapy replaces estrogen and when needed, progesterone
Ontario Drug Benefit Formulary, Part V, 2026-09-03, p. 38
68:16 Estrogens
68:32 Progestogens and Oral Contraceptives